| 注册
首页|期刊导航|中国临床药理学杂志|脑肿瘤患儿WTAP rs7766006位点遗传多态性与化疗毒性及临床预后的相关性研究

脑肿瘤患儿WTAP rs7766006位点遗传多态性与化疗毒性及临床预后的相关性研究

刘正跃 孟令嘉 闫安 李苗 王淑梅

中国临床药理学杂志2026,Vol.42Issue(7):920-926,7.
中国临床药理学杂志2026,Vol.42Issue(7):920-926,7.DOI:10.13699/j.cnki.1001-6821.2026.07.004

脑肿瘤患儿WTAP rs7766006位点遗传多态性与化疗毒性及临床预后的相关性研究

Associations of WTAP rs7766006 polymorphisms on chemotherapy toxicities and clinical prognosis in children with brain tumors

刘正跃 1孟令嘉 1闫安 1李苗 2王淑梅1

作者信息

  • 1. 首都医科大学附属北京世纪坛医院药学部,北京 100038
  • 2. 首都医科大学附属北京世纪坛医院药学部,北京 100038||首都医科大学附属北京世纪坛医院儿科,北京 100038
  • 折叠

摘要

Abstract

Objective To explore the effects of Wilms tumor 1-associating protein(WTAP)rs7766006 polymorphisms on chemotherapy toxicities and clinical prognosis in children with brain tumors.Methods Pediatric patients with brain tumors who received chemotherapy at our hospital were included as study subjects.Matrix-assisted laser desorption/ionization time of flight mass spectrometry was used for WTAP rs7766006 genotyping.Clinical data collected included chemotherapy toxicities and tumor progression.The associations of WTAP rs7766006 G>T polymorphisms with chemotherapy toxicities and progression-free survival(PFS)were analyzed.The expression of WTAP in brain tumors and its prognostic significance,and the potential mechanism of rs7766006 G>T polymorphisms in WTAP expression were explored based on bioinformatics methods.Results Among the 107 children with brain tumors included,the rs7766006 GG homozygous,GT heterozygous,and TT homozygous genotypes accounted for 40.19%(43 cases/107 cases),44.86%(48 cases/107 cases)and 14.95%(16 cases/107 cases),respectively.The frequencies of G and T alleles were 62.62%(134 cases/214 cases)and 37.38%(80 cases/214 cases)respectively.The incidence rates of mucositis in the GG,GT,and TT genotype groups were 53.49%(23cases/43 cases),27.08%(13 cases/48 cases)and 43.75%(7 caes/16 cases),respectively.The incidence rates of coagulation disorders in three groups were 18.61%(8 cases/43cases),2.08%(1 case/48 cases)and 6.25%(1 case/16 cases),respectively.The difference in the incidence rates of the two chemotherapy toxicities mentioned above between the GG and GT genotypes was statistically significant(all P<0.05).However,there were no significant differences in the incidence of other chemotherapy toxicities among the three groups(all P>0.05).The disease progression rates for the GG,GT,and TT genotype groups were 65.12%(28 cases/43 cases),43.75%(21 cases/48 cases),and 62.50%(10 cases/16 cases),respectively.The risk of disease progression in children with the GG genotype was significantly higher than in those with the GT genotype(P<0.05).Bioinformatics analysis showed that the WTAP expression in brain tumors 6.00±0.66 was significantly higher than that in normal tissues 4.63±1.34(P<0.001).The median overall survivals for the WTAP high-expression group and the low-expression group were 537 and 2 835 days,respectively(P<0.001).The rs7766006 polymorphism was located in the exonic splicing enhancer site and possibly regulated WTAP expression by affecting alternative splicing.Conclusion WTAP rs7766006 GG genotype might be a risk factor for oral mucositis,coagulation disorders,and progression in children with brain tumors.

关键词

脑肿瘤/Wilms肿瘤1相关蛋白/单核苷酸多态性/化疗毒性/预后

Key words

brain tumor/Wilms tumor 1-associating protein/single nucleotide polymorphism/chemotherapy toxicity/prognosis

分类

医药卫生

引用本文复制引用

刘正跃,孟令嘉,闫安,李苗,王淑梅..脑肿瘤患儿WTAP rs7766006位点遗传多态性与化疗毒性及临床预后的相关性研究[J].中国临床药理学杂志,2026,42(7):920-926,7.

基金项目

国家自然科学基金资助项目(81872926) (81872926)

中国临床药理学杂志

1001-6821

访问量0
|
下载量0
段落导航相关论文